• OPEN AN ACCOUNT
Indian Indices
Nifty
25,476.10 -46.40
(-0.18%)
Sensex
83,536.08 -176.43
( -0.21%)
Bank Nifty
57,213.55 -42.75
( -0.07%)
Nifty IT
38,680.85 -302.40
( -0.78%)
Global Indices
Nasdaq
44,269.23 -158.14
(-0.36%)
Dow Jones
6,248.01 -2.97
(-0.05%)
Hang Seng
39,748.89 60.08
(0.15%)
Nikkei 225
8,867.02 12.84
(0.15%)
Forex
USD-INR
85.79 0.80
(0.94%)
EUR-INR
100.70 0.65
(0.65%)
GBP-INR
116.80 0.89
(0.77%)
JPY-INR
0.59 0.00
(0.30%)

EQUITY - MARKET SCREENER

Bombay Super Hybrid Seeds Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
535077
INE032Z01020
9.9758378
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BSHSL
55.91
1478.46
EPS(TTM)
Face Value()
Div & Yield %
2.52
1
0
 

GKB Ophthalmics Ltd - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
Mar 31,2025
Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations 2015 (PIT Regulations 2015) intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF) has purchased 210 equity shares aggregating of Rs. 17705.36 /- from 25.02.2025 to 25.02.2025 on market which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation 2015. However as a good Corporate Governance measure the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation 2015 is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta & Sons-HUF . Please acknowledge and take the same on record.